These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1394629)

  • 1. Syntheses of a glycerophospholipid, C16-platelet activating factor and a palmitoyl analogue of M-5, an anti-inflammatory glyceroglycolipid.
    Shibuya H; Kawashima K; Narita N; Kitagawa I
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1166-9. PubMed ID: 1394629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
    Tanaka T; Iimori M; Tsukatani H; Tokumura A
    Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid synthesis].
    Evstigneeva RP
    Izv Akad Nauk SSSR Biol; 1978; (5):707-16. PubMed ID: 361789
    [No Abstract]   [Full Text] [Related]  

  • 4. Catalytic synthesis of enantiopure mixed diacylglycerols – synthesis of a major M. tuberculosis phospholipid and platelet activating factor.
    Fodran P; Minnaard AJ
    Org Biomol Chem; 2013 Sep; 11(40):6919-28. PubMed ID: 24191360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of azathia analogues of platelet activating factor with polyheterosidechains.
    Zeidler JM; Zimmermann W; Roth HJ
    Chem Phys Lipids; 1990 Aug; 55(2):155-61. PubMed ID: 2090358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of platelet activation factor analogs].
    Sablina MA; Ushakova IP; Dement'eva EV; Dergousov AA; Serebrennikova GA
    Bioorg Khim; 1993 Mar; 19(3):354-9. PubMed ID: 8489534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells.
    Hichami A; Duroudier V; Leblais V; Vernhet L; Le Goffic F; Ninio E; Legrand A
    Eur J Biochem; 1997 Dec; 250(2):242-8. PubMed ID: 9428670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-inflammatory activity of structural analogs of the platelet-activating factor].
    Melikiants AG; Kulikov VI; Koloskova EE; Kuznetsova TI; Dergousov AA; Lipatkina LIu
    Farmakol Toksikol; 1991; 54(4):43-5. PubMed ID: 1786825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
    Duffy-Krywicki RH; Steinhelper ME; Olson MS
    J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
    Triggiani M; Chilton FH
    Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic studies on platelet-activating factor (PAF).
    Suemune H; Akashi A; Sakai K
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1055-61. PubMed ID: 4028291
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of dialkyl ether phospholipids. I. Chemical synthesis of some model compounds.
    Chen JS; Barton PG
    Can J Biochem; 1970 May; 48(5):585-93. PubMed ID: 5525013
    [No Abstract]   [Full Text] [Related]  

  • 13. [PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].
    Kertscher HP; Ostermann G; Findeisen M; Limmer S; Gawrisch K
    Pharmazie; 1991 Aug; 46(8):575-9. PubMed ID: 1798710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of heterocyclic platelet activating factor analogues.
    Zeidler J; Zimmermann W
    Chem Phys Lipids; 1995 Feb; 75(2):183-91. PubMed ID: 7743564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group.
    Kern H; Volk T; Knauer-Schiefer S; Mieth T; Rüstow B; Kox WJ; Schlame M
    Biochim Biophys Acta; 1998 Oct; 1394(1):33-42. PubMed ID: 9767093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
    Vlachogianni IC; Fragopoulou E; Stamatakis GM; Kostakis IK; Antonopoulou S
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):176-83. PubMed ID: 26358846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the phytanyl diether analogs of phosphatidyl glycerophosphate and phosphatidyl glycerol present in Halobacterium cutirubrum.
    Joo CN; Kates M
    Biochim Biophys Acta; 1968 Jul; 152(4):800-3. PubMed ID: 5660096
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
    Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the naturally occurring phytanyl diether analogs of phosphatidyl glycerophosphate and phosphatidyl glycerol.
    Joo CN; Kates M
    Biochim Biophys Acta; 1969 Mar; 176(2):278-97. PubMed ID: 5775948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cord factor and its analogs. III. Synthesis of cord factor (6,6'-di-O-mycoloyl-alpha, alpha-trehalose) and 6,6'-di-O-palmitoyl-alpha, alpha-trehalose].
    Toubiana R; Das BC; Defaye J; Mompon B; Toubiana MJ
    Carbohydr Res; 1975 Nov; 44(2):308-12. PubMed ID: 1203908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.